Dr. Samuel Hanon

Zyad Younan is a Cardiac Electrophysiologist and a Cardiologist in Parlin, New Jersey. Dr. Younan is rated as a Distinguished provider by MediFind in the treatment of Myocarditis. His top areas of expertise are Cardiomyopathy, Arrhythmias, Atrial Fibrillation, Pacemaker Implantation, and Cardiac Ablation.

Luigi Di Biase, MD, PhD, FACC, FHRS, is Section Head of Electrophysiology and Director of Arrhythmia Services at Montefiore as well as Professor of Medicine (Cardiology) at our Albert Einstein College of Medicine. Dr. Di Biase is rated as an Elite provider by MediFind in the treatment of Myocarditis. His top areas of expertise are Atrial Fibrillation, Arrhythmias, Ventricular Tachycardia, Cardiac Ablation, and Pacemaker Implantation.

Dr. Emad Aziz is a Professor of Medicine and Section Chief of Cardiac Electrophysiology and Director of the Arrhythmia Institute at the Rutgers-NJMS University Hospital. Dr. Aziz is triple certified by the American Osteopathic Board of Internal Medicine, the American Osteopathic Board of Cardiology, and Cardiac Electrophysiology. Dr. Aziz completed his residency training in Internal Medicine and fellowships in Cardiology and Clinical Cardiac Electrophysiology at St. Luke’s-Roosevelt Hospital Center, a University Hospital of Columbia University College of Physicians and Surgeons, along with a fellowship in Advanced Heart Failure at Montefiore-Einstein Heart Institute. He is a fellow of the American College of Cardiology and a fellow of the Heart Rhythm Society. Since coming to NJMS, there has been significant growth of the electrophysiology department with the latest innovations in rhythm management now being offered in both in- and outpatient settings. The procedure volume of the EP lab has increased by over 400% compared to the prior year. Dr. Aziz has introduced new procedures not previously offered in the state of NJ, including the Impulse Dynamic implantation and Wise-CRT device, through the international SOLVE-CRT trial, for advanced heart failure. University Hospital is also the first site in the state to use the newly approved MICRA AV leadless pacemaker.University Hospital will also be one of the first institutions in the country to offer Respicardia Remedē device for central sleep apnea. In addition to the SOLVE-CRT trial, Rutgers is also enrolled in two other clinical trials: MARVEN study sponsored through NIH looking at risk factors associated with ventricular tachyarrhythmias in non-ischemic cardiomyopathy and the SAF-ILR trial studying the safety and cost effectiveness of same day loop recorder implantation vs. traditional telemetry observation for patients with unexplained syncope. Dr. Aziz is actively involved in education and established an EP rotation for residents and an EP curriculum for fellows, including weekly ECG rounds as well as fostering multiple active research projects. He has extensively published more than 170 abstracts, over 100 manuscripts, and book chapters in peer-reviewed and professional journals. Dr. Aziz has future endeavors that include developing an ACGME accredited Electrophysiology fellowship program, comprehensive atrial fibrillation and advanced ventricular tachycardia management programs as well as introducing stereotaxis GENESIS system for advanced robotic ablations. Dr. Aziz is rated as a Distinguished provider by MediFind in the treatment of Myocarditis. His top areas of expertise are Atrial Fibrillation, Arrhythmias, Sick Sinus Syndrome, Pacemaker Implantation, and Cardiac Ablation.